All Posts
CRESTONE: Clinical study of response to seribantumab in tumors with neuregulin-1 (NRG1) fusions—A phase II study of the anti-HER3 mAb for advanced or metastatic solid tumors (NCT04383210)
Study Name CRESTONE: Clinical study of response to seribantumab in tumors with neuregulin-1 (NRG1) fusions—A phase II study of the…
Music Video/Lip Sync for the 2021 Annual Conference
The 2021 Cholangiocarcinoma Foundation Virtual Conference is only a few short weeks away. CCF plans to have some fun during…
Five for Friday – 5 clinical trials presented at GI ASCO
Home / Blog / [wpbb post:title] The American Society of Clinical Oncology Gastrointestinal Cancers Symposium (GI ASCO) recognizes the important…
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Study Name CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors ClinicalTrials.gov Identifier (if applicable) NCT04660929 Clinical Trial Category (check…
Cholangiocarcinoma Foundation Celebrates 15th Anniversary Milestone
FDA Approves Incyte's Pemazyre™ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma…
Five for Friday – 5 takeaways from GI ASCO
Home / Blog / [wpbb post:title] The American Society of Clinical Oncology Gastrointestinal Cancers Symposium (GI ASCO) is an annual…
Cholangiocarcinoma Foundation Launches Trusted Partners Program
FDA Approves Incyte's Pemazyre™ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma…
Five for Friday – 5 reasons why you should participate in research with Ciitizen
Home / Blog / [wpbb post:title] You are the future of research, and we want you to know that your…
Regina (Regi) Elizabeth Blair
Regina (Regi) Elizabeth Blair, 64, passed away surrounded by loved ones after a courageous battle with Extrahepatic Cholangiocarcinoma, a rare…
Five for Friday – 5 events to add to your calendar as we begin the new year
Home / Blog / [wpbb post:title] We hope you had a Happy New Year! Exciting things are happening at Cholangiocarcinoma…